Condensed Statements of Changes in Stockholders' Deficit - USD ($) $ in Thousands	Total	Warrant exercises	Public Equity Offering - ATM	Public Equity Offering	Common Stock	Common Stock Warrant exercises	Common Stock Public Equity Offering - ATM	Common Stock Public Equity Offering	Additional Paid-in Capital	Additional Paid-in Capital Warrant exercises	Additional Paid-in Capital Public Equity Offering - ATM	Additional Paid-in Capital Public Equity Offering	Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2022					54,827,734
Beginning balance at Dec. 31, 2022	$ (118,554)				$ 55				$ 192,598				$ (311,207)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common Stock issued under public equity offering (in shares)								1,078,622
Common Stock issued under public equity offering				$ 993				$ 1				$ 992
Costs of common stock issued under public equity offering				(77)								(77)
Share-based compensation expense	344								344
Vested restricted stock units, net (in shares)					16,005
Vested restricted stock units, net	(8)								(8)
Other	(1)								(1)
Net (loss) income	8,068												8,068
Ending balance (in shares) at Mar. 31, 2023					55,922,361
Ending balance at Mar. 31, 2023	(109,235)				$ 56				193,848				(303,139)
Beginning balance (in shares) at Dec. 31, 2022					54,827,734
Beginning balance at Dec. 31, 2022	(118,554)				$ 55				192,598				(311,207)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net (loss) income	241
Ending balance (in shares) at Sep. 30, 2023					66,740,765
Ending balance at Sep. 30, 2023	(102,927)				$ 67				207,972				(310,966)
Beginning balance (in shares) at Dec. 31, 2022					54,827,734
Beginning balance at Dec. 31, 2022	(118,554)				$ 55				192,598				(311,207)
Ending balance (in shares) at Dec. 31, 2023					68,533,085
Ending balance at Dec. 31, 2023	(106,487)				$ 69				212,521				(319,077)
Beginning balance (in shares) at Mar. 31, 2023					55,922,361
Beginning balance at Mar. 31, 2023	(109,235)				$ 56				193,848				(303,139)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common Stock issued under public equity offering (in shares)						3,689,452		1,981,937
Common Stock issued under public equity offering		$ 3,542		4,409		$ 4		$ 2		$ 3,538		4,407
Costs of common stock issued under public equity offering				(235)								(235)
Shares issued under employee stock purchase plan (in shares)					18,699
Shares issued under employee stock purchase plan	31								31
Share-based compensation expense	631								631
Vested restricted stock units, net (in shares)					3,510
Vested restricted stock units, net	(3)								(3)
Other	1								1
Net (loss) income	(5,792)												(5,792)
Ending balance (in shares) at Jun. 30, 2023					61,615,959
Ending balance at Jun. 30, 2023	(106,651)				$ 62				202,218				(308,931)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common Stock issued under public equity offering (in shares)						5,000,000		124,181
Common Stock issued under public equity offering		$ 4,800		264		$ 5				$ 4,795		264
Costs of common stock issued under public equity offering				(80)								(80)
Share-based compensation expense	$ 774								774
Options exercises, net (in shares)	625
Options exercised, net	$ 1
Net (loss) income	(2,035)												(2,035)
Ending balance (in shares) at Sep. 30, 2023					66,740,765
Ending balance at Sep. 30, 2023	(102,927)				$ 67				207,972				(310,966)
Beginning balance (in shares) at Dec. 31, 2023					68,533,085
Beginning balance at Dec. 31, 2023	(106,487)				$ 69				212,521				(319,077)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common Stock issued under public equity offering (in shares)							4,557,220	16,666,667
Common Stock issued under public equity offering			$ 12,385	75,000			$ 4	$ 17			$ 12,381	74,983
Costs of common stock issued under public equity offering			(410)	(5,187)							(410)	(5,187)
Share-based compensation expense	1,580								1,580
Vested restricted stock units, net (in shares)					490,359
Vested restricted stock units, net	$ (893)								(893)
Options exercises, net (in shares)	231,400
Options exercised, net	$ 539
Net (loss) income	(12,828)												(12,828)
Ending balance (in shares) at Mar. 31, 2024					90,478,731
Ending balance at Mar. 31, 2024	(36,301)				$ 90				295,514				(331,905)
Beginning balance (in shares) at Dec. 31, 2023					68,533,085
Beginning balance at Dec. 31, 2023	(106,487)				$ 69				212,521				(319,077)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net (loss) income	(27,082)
Ending balance (in shares) at Sep. 30, 2024					91,178,193
Ending balance at Sep. 30, 2024	(45,420)				$ 91				300,648				(346,159)
Beginning balance (in shares) at Mar. 31, 2024					90,478,731
Beginning balance at Mar. 31, 2024	(36,301)				$ 90				295,514				(331,905)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common Stock issued under public equity offering (in shares)								559,801
Common Stock issued under public equity offering				2,520				$ 1				2,519
Costs of common stock issued under public equity offering			$ (158)	$ (359)							$ (158)	$ (359)
Shares issued under employee stock purchase plan (in shares)					17,716
Shares issued under employee stock purchase plan	46								46
Share-based compensation expense	1,523								1,523
Vested restricted stock units, net (in shares)					3,512
Vested restricted stock units, net	(5)								(5)
Net (loss) income	(2,745)												(2,745)
Ending balance (in shares) at Jun. 30, 2024					91,059,760
Ending balance at Jun. 30, 2024	(35,479)				$ 91				299,080				(334,650)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Share-based compensation expense	1,577								1,577
Vested restricted stock units, net (in shares)					(7,192)
Vested restricted stock units, net	(202)								(202)
Options exercises, net (in shares)					125,625
Options exercised, net	193								193
Net (loss) income	(11,509)												(11,509)
Ending balance (in shares) at Sep. 30, 2024					91,178,193
Ending balance at Sep. 30, 2024	$ (45,420)				$ 91				$ 300,648				$ (346,159)